Detail akcie TherapeuticsMD Rg online

Business Summary: TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Financial Summary: BRIEF: For the nine months ended 30 September 2025, TherapeuticsMD Inc revenues increased 95% to $2.1M. Net loss before extraordinary items decreased 98% to $41K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Sublease income increase from $275K to $910K (income), Depreciation and amortization decrease of 30% to $287K (expense).